Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 5, 2012, Pages 398-402

  De Luis, Daniel Antonio ^a   Soto, Gonzalo Diaz ^a   Conde, Rosa ^a   Izaola, Olatz ^a   de la Fuente, Beatriz ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adiponectin; Leptin; Primary hyperparathyroidism

Indexed keywords

ADIPONECTIN; CALCIUM; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPENDENT VARIABLE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADIPOKINES; AGED; BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; RISK FACTORS; STATISTICS, NONPARAMETRIC; VITAMIN D;

EID: 84866619317     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21541     Document Type: Article

References (19)

1. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol CHem 2002;277:37487-37491
2. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89.
3. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76.
4. Delfini E, Petramala L, Caliumi C, Cotesta D, De toma G, Cavallaro G. Circulating leptin and adiponectin levels in patients with primary hyperparathyridism. Metab Clin Exp 2007;56:30-36.
5. Kaplan EL, Yashro T, Salti G. Primary hyperparathyroidism in the 1990s. Ann Surg 1992;215:300-317.
6. Hedback G, Oden A. Increased risk of death from primary hyperparathyroidism-An update. Eur J Clin Invest 1998;28:271-276.
7. Anderson P, Ridberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 2004;25:1777-1787.
8. Letizia C, Ferrari P, Cotesta D, et al. Ambulatory monitoring of blood pressure (AMBP) in patients with primary hyperparathyroidism. J Hum Hypertens 2005;19:901-906.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: (Adult Treatment Panel III). JAMA 2001;285(19):2486-2497.
10. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
11. Meier U, Gressner M. Endocrine regulation of energy metabolis: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511-1525.
12. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004;50:219-221.
13. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41(4):810-817.
14. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Granada: Ed. University of Granada; 2003.
15. Speakman JR, Stubbs RJ, Mercer JG. Does body mass play a role in the regulation of food intake? Proc Nutr Soc 2002;61:473-487.
16. Mantzmoros CS, Manson JE, Meigs J, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favourable lipid profile and rediced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:4542-4548.
17. Zoccari C, Panuccio V, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol 2004;17:253-260.
18. Coen G, Ballanti P, Fischer MS, et al. Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 2003;42:1036-1042.
19. Bhadada S, Bhansali A, Shah VN, Rao DS. Changes in serum leptin and adiponectina concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism. Signapore Med J 2011;52:890-893.